JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Jin Medical International Ltd. engages in the design, development, manufacture, and sale of wheelchair and other living aids for people with disabilities, the elderly, and people recovering from injury. The company offers wheelchairs and wheelchair components, such as wheels and brakes; oxygen concentrators, bath aids, and rehabilitative devices, as well as infrastructures for shared wheelchairs … Read more
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) - Net Assets
Latest net assets as of September 2025: $29.57 Million USD
Based on the latest financial reports, JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) has net assets worth $29.57 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($53.37 Million) and total liabilities ($23.80 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $29.57 Million |
| % of Total Assets | 55.41% |
| Annual Growth Rate | 18.52% |
| 5-Year Change | 110.8% |
| 10-Year Change | N/A |
| Growth Volatility | 17.97 |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares - Net Assets Trend (2018–2025)
This chart illustrates how JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (2018–2025)
The table below shows the annual net assets of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares from 2018 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-09-30 | $29.57 Million | +3.57% |
| 2024-09-30 | $28.55 Million | +19.07% |
| 2023-09-30 | $23.98 Million | +57.39% |
| 2022-09-30 | $15.24 Million | +8.60% |
| 2021-09-30 | $14.03 Million | +29.87% |
| 2020-09-30 | $10.80 Million | +0.91% |
| 2019-09-30 | $10.71 Million | +18.93% |
| 2018-09-30 | $9.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 330.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $20.94 Million | 70.65% |
| Other Components | $8.70 Million | 29.35% |
| Total Equity | $29.64 Million | 100.00% |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares Competitors by Market Cap
The table below lists competitors of JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GuocoLand (Malaysia) Bhd
KLSE:1503
|
$21.92 Million |
|
Coventry Group Ltd
AU:CYG
|
$21.92 Million |
|
Veracruz Properties SOCIMI SA
MC:YVCP
|
$21.92 Million |
|
Teladan Setia Group Bhd
KLSE:0230
|
$21.93 Million |
|
Pan Global Resources Inc.
OTCQX:PGZFF
|
$21.91 Million |
|
Beaconsmind AG
PA:MLBMD
|
$21.90 Million |
|
Bayrak EBT Taban Sanayi ve Ticaret Anonim Sirketi
IS:BAYRK
|
$21.88 Million |
|
Lustrum Minerals Limited
AU:LRM
|
$21.87 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 28,815,184 to 29,638,722, a change of 823,538 (2.9%).
- Net income of 1,191,297 contributed positively to equity growth.
- Other comprehensive income decreased equity by 2,036,867.
- Other factors increased equity by 1,669,108.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $1.19 Million | +4.02% |
| Other Comprehensive Income | $-2.04 Million | -6.87% |
| Other Changes | $1.67 Million | +5.63% |
| Total Change | $- | 2.86% |
Book Value vs Market Value Analysis
This analysis compares JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.41x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 104.43x to 12.41x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-09-30 | $0.02 | $2.35 | x |
| 2019-09-30 | $0.03 | $2.35 | x |
| 2020-09-30 | $0.03 | $2.35 | x |
| 2021-09-30 | $0.05 | $2.35 | x |
| 2022-09-30 | $0.11 | $2.35 | x |
| 2023-09-30 | $0.15 | $2.35 | x |
| 2024-09-30 | $0.18 | $2.35 | x |
| 2025-09-30 | $0.19 | $2.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.02%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.76%
- • Asset Turnover: 0.39x
- • Equity Multiplier: 1.80x
- Recent ROE (4.02%) is below the historical average (20.09%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 40.90% | 17.61% | 1.12x | 2.08x | $2.78 Million |
| 2019 | 34.07% | 17.91% | 1.00x | 1.90x | $2.58 Million |
| 2020 | 20.42% | 13.62% | 0.78x | 1.93x | $1.13 Million |
| 2021 | 18.76% | 12.67% | 0.95x | 1.56x | $1.23 Million |
| 2022 | 17.76% | 14.10% | 0.92x | 1.37x | $1.18 Million |
| 2023 | 12.00% | 14.52% | 0.60x | 1.37x | $480.32K |
| 2024 | 12.76% | 15.64% | 0.51x | 1.59x | $794.41K |
| 2025 | 4.02% | 5.76% | 0.39x | 1.80x | $-1.77 Million |
Industry Comparison
This section compares JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) | $29.57 Million | 40.90% | 0.80x | $21.92 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |